Purpose : We performed this study to investigate the characteristic imaging and clinicopathologic features of invasive micropapillary carcinoma of the breast.
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Invasive micropapillary carcinoma (IMPC) of the breast is a rare variant of invasive ductal carcinoma, which accounts for 0.7-3% of all breast cancers (1, 2) .
IMPC is a unique pathologic entity characterized by pseudo-papillary structures floating in empty, clear spaces lined by delicate strands of stroma. IMPC shows clinically aggressive prognosis with invasion to lymphatic system, extensive axillary lymph node involvement, frequent local recurrence and distant metastasis. This tumor has been described as a morphologically distinctive entity by Petersen in 1993 (2) and several articles on IMPC are found in the pathology literature (1, (3) (4) (5) (6) , but a few articles has described its imaging features (7, 8) . Knowledge of the imaging findings of IMPC would be useful to diagnose this disease. IMPC is rare variant of the breast cancer, but clinician and radiologist can regard this disease as one of the possible diagnosis. However, there is scant information in the medical literature describing this topic.
The purpose of this study is to retrospectively evaluate the imaging findings of IMPC and to identify the characteristic imaging and clinical findings.
Patient selection
In our breast surgery database, from 2005 to 2009, 4,139 women underwent breast cancer surgeries. Among them, 47 had been diagnosed with IMPC of the breast and 32 of them had undergone all three preoperative images of mammography, ultrasonography (US), and magnetic resonance (MR) imaging. We excluded 15 patients who didn't perform the preoperative MR imaging. The mean age was 50 years; range, 37-69 years at the time of diagnosis. The mode of presentation was divided into symptomatic or asymptomatic presentation. This study was approved by our institutional review board. As images were analyzed retrospectively, the requirement for informed consent was waived.
Image review
Two radiologists who are specialized in breast imaging retrospectively reviewed all the preoperative images in consensus. All the imaging findings were described using the American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS) lexicon (9) with some modification.
Standard two-view mammography was performed with digital mammography equipment (Senographe 2000D or DMR; General Electric Medical Systems, Buc, France). Breast parenchymal density was categorized as fatty, heterogeneously dense, and extremely dense according to the lexicon (9) . Mammograms were reviewed for type of lesions (mass or asymmetry with calcifications, mass or asymmetry without calcifications, calcifications only and negative findings), shape of microcalcifications.
US examinations were performed with 7-12 MHz linear transducer (HDI 3000, 5000 or iU22; Philips Medical Systems, Bothell, WA or Logiq 700; General Electric, Milwaukee, WI) by radiologists. Sonograms were assessed for the type of the lesion (mass, nonmass-forming heterogeneity), shape, margin, and echogenecity. According to BI-RADS lexicon, the echogenecity of mass is classified as hyperechoic, isoechoic, hypo echoic and anechoic. Because hypoechogenicity has a wide range, we divided hypoechogenicity into "mildly hypoechoic," which was slightly less echogenic than subcutaneous fat tissue and "markedly hypoechoic," which was much more hypoechoic approaching to blackness. We analyzed the category of the lesions according to the radiologic reports.
MR imaging was performed at 1.5 T with a wholebody imaging system (Signa EXCITE; GE Healthcare, Milwaukee, Wis, Achieva; Philips) and a dedicated four-channel breast coil. The patient was prone, and images were acquired with the following sequences: unenhanced axial T1-weighted spin echo (TR/TE, 500/10); axial T2-weighted fat-suppressed fast spin echo (5500/70); dynamic contrast enhanced axial or The field of view was 160-220 mm, and the matrix size was 256 × 256 pixels. After examination, two subtraction images were automatically made on a pixel-by-pixel basis: the un-enhanced images were subtracted from the early post-contrast images (standard subtraction), and the last post-contrast images were subtracted from the early post-contrast images (reverse subtraction). The reformatted images with a maximum intensity projection were then created from the standard and reverse subtraction images. Areas of abnormal enhancement were described as mass or non-mass like, and enhancement kinetics, especially focused on the washout pattern, were reviewed. The kinetic curves were analyzed by using a computer aided detection (CAD) software (CADstream).
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Histopathologic review
Histopathologic diagnosis was made by the surgical excision. We reviewed pathologic report for assessment of the tumor size, nuclear grade, histologic grade, presence of endolymphatic tumor emboli and axillary lymph node. We reviewed the pathologic result of immunohistochemical analyses for estrogen receptor (ER), progesterone receptor (PR), and c-erb B-2.
Patients
The imaging findings, clinical presentation, and pathologic findings are summarized in Table 1 . Clinical symptom was associated with 23 of 32 patients (72%). IMPCs were diagnosed from palpable breast masses in 22 patients (69%) and bloody nipple discharge in one (3%). Nine patients (28%) had an incidental abnormality detected on screening mammography (n = 6), US (n = 2) or positron emission tomography (n = 1). The right breast was involved in 18 patients (56%) and the left breast in 14 patients (44%).
Mammography
The background parenchymal density was BI-RADS type 1 pattern in 1, type 2 pattern in 8, type 3 in 16, type 4 in 7 patients. The mammographic findings in 32 patients were as follows: mass or focal asymmetry with calcifications in 15 (47%) (Figs. 1-3 ), calcifications only in 5 (16%) (Fig. 4) , mass or asymmetry in 9 (28%) (Fig. 5) , and no abnormality in 3 (9%) patients ( 
Ultrasonography
Sonographic findings of 32 patients are presented in Table 2 . On US, the abnormal findings were seen in all cases and classified into BI-RADS category 4b (n = 8), 4c (n = 6), or 5 (n = 18). A single mass (n = 20) or multiple masses (n = 10) were visible in 30 (94%) patients (Figs. 1-3 , 5-6), and non-mass like heterogeneity was found in two patients (6%) (Fig. 4) . The mean tumor size on ultrasonography was 2.3 cm (range, 0.8-8.0 cm). The masses usually showed an irregular shape and hypoechogenicity in all except one (Figs. 1, 2, 5, 6 ). The echogenicity was especially markedly hypoechoic in 20 (20/30, 66.7%) (Figs. 1, 2,  5) . Most of the masses showed suspicious findings in their margin: indistinct (n = 6), microlobulated (n = 8) and spiculated (n = 15). Only one mass detected during work-up of abnormal uptake of positronemission tomography-computed tomography (PET-CT) showed an oval circumscribed isoechoic mass (Fig. 3) . The sonographic finding of the mass seemed to probably benign mass, but it shows increased uptake on PET-CT and it categorized to BI-RADS category 4b. The two cases, a suspicious mass was detected during supplemental US screening and the mass showed typical malignant features (Fig. 6 ).
MR imaging
On MR imaging, the abnormal findings were seen in all cases and classified into BI-RADS category 4c or 5. The type of lesions was a single mass or multiple masses in 23 (72%) (Figs. 1, 3, 5, 6 ), mass associated with non-mass like enhancement in 6 (19%) (Fig. 2) , and only non-mass like enhancement in 3 (9%) (Fig.   4 ). Of the 23 mass lesions, the shape of the mass was irregular in 19 and oval or lobular in 4. The margin was irregular or spiculated in 16 (Figs. 1, 5 ) and smooth with rim enhancement in seven (Figs. 3, 6 ). Of the 9 non-mass like enhancing lesions, seven showed clumped segmental pattern (Fig. 4) , and two showed regional heterogeneous pattern.
On dynamic MR kinetics, all lesions showed initial rapid enhancement and 29 (91%) lesions showed washout kinetics (Figs. 2, 5 ) and three (9%) lesions showed persistent enhancement. In two lesions, trabecular thickening and enhancement were noted like inflammatory breast cancers.
Multiplicity was observed in ten (31%) cases. In one case, MR imaging depicted a tumor in the contralateral breast that was mammographically and sonographically occult. MR imaging also detected another malignant lesions in the ipsilateral breast that were mammographically and sonographically occult in three cases. 
Histopathologic findings
Sixteen patients (50%) underwent modified radical or total mastectomy due to the large size of invasive tumors or wide area of ductal carcinoma in situ (n = 14), subareolar location (n = 1) and the patient's request (n = 1). Nine patients underwent neoadjuvant chemotherapy before the surgery. The mean tumor size in the patients who did not receive neoadjuvant chemotherapy (n = 23) was 1.9 cm (range, 1.0-4.6 cm) and among them, 16 had T1 cancers (tumor size < 2 cm). Nuclear grade was high in 22 (67%), intermediate in eight (25%), and low in 2 (6%). Histologic grade was poorly-differentiated in 14 cases (44%), moderately differentiated in 16 (50%), and welldifferentiated in 2 (6%). Endolymphatic tumor emboli were seen in 27 (84%) cases. Histologic axillary lymph node metastasis was present in 25 (78%) cases (Figs. 1-4) . Among the cases with lymph node metastasis, the suspicious lymph nodes were seen in 16 cases (64%) on preoperative US or MR images. In 6 of them, the enlarged lymph nodes were seen as only equivocal cortical thickening less than 3 mm on US but US-guided aspiration revealed a metastasis in all cases.
Immunohistochemical analyses were available for all patients. The analysis showed the expression of ERs in 81.2% of the cases (26 of 32), PRs in 71.8% of the cases (23 of 32) and c-erbB-2 in 42.7% of the cases (14 of 32).
To our knowledge, our study of 32 patients with IMPC is the largest series to date describing the MR (10) . It occurs as only a small focus of stromal invasion at the periphery of the lesion and may have various growth patterns, either retaining a papillary pattern or, more commonly, spreading as a ductal carcinoma of the usual type (10). On mammography, invasive papillary carcinoma is seen as a solitary round, oval, or lobulated circumscribed mass or as clusters of welldefined masses. Masses may be associated with microcalcifications. On sonography, single or multiple circumscribed solid of complex mixed cystic and solid masses. Invasive papillary carcinoma could not be differentiated from benign papillomas using these imaging features alone (10, 11) . This has a slow growth rate and less axillary nodal involvement, so patients with invasive papillary carcinoma have a better prognosis than do other forms of ductal carcinomas. Contrast to this, micropapillary DCIS, a variant of DCIS, shows frond-forming growth pattern, but does not have a fibrovascular core. It often ramify extensively in the ductal system (11). Since calcifications are usually not present and may be seen as architectural distortion on mammography, the modality of choice to determine the extent of the lesion is breast MR imaging (11, 12) .
DISCUSSION
Clinically, the most common clinical manifestation of IMPC in our study was a palpable mass (69%), similar to previous studies (7, 8) . There were 9 asymptomatic cases that were detected by screening examinations, mostly initially detected by mammography. The mammographic appearance of IMPC has been described in previous series as irregular shaped indistinct or spiculated high density mass with spiculated margin (13) . Microcalcifications, either isolated or associated with a mass, were present in 43-68% in previous studies (7, 8, 13) and our group showed a similar rate (63%). Furthermore, in our series, the calcifications had more frequently amorphous or punctuate shape (60%).
Although there were 3 cases of mammographically negative IMPC, all lesions were seen on US and MR imaging both. The most common sonographic feature in our study was irregularly shaped solid mass without cystic change. The mass (es) was usually markedly, Invasive Micropapillary Carcinoma of the Breast � Sun Jung Rhee, et al. homogeneously, hypoechoic. The marked homogeneous hypoechogenicity may represent high cellularity on histologic examinations. IMPC is usually composed of high nuclear grade malignant cells surrounded by clear spaces resembling lymphovascular channels and this hypercellularity may be related with homogeneous hypoechogenicity on US. On histopathologic comparison, the homogeneously hypoechoic pattern of the IPMC usually corresponded to the large-field, uniform cluster of tumor cells. In that pattern, acoustic impedances of the tumor were similar and differences in acoustic impedance were rare; therefore, the reflected echoes were less than those usually surrounding tissue, resulting in homogeneous hypoechogenicity (14) . Posterior acoustic shadowing was not distinctive findings of this tumor like the other report (7, 8) .
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MR imaging is generally accepted as a more sensitive technique than mammography or sonography for the detection of breast cancers. The use of dynamic imaging and pharmacokinetics analysis of dynamic data has increased detection specificity (15, 16) . In our study, a combined pattern with a mass and non-mass was observed in 6 cases (21%) on MR imaging. These were seen as a single mass on sonography. Intense heterogeneous enhancement, with rapid initial increase and washout kinetics on dynamic contrastenhanced images was predominant (92%) and these features are characteristics of malignancy. MR imaging depicted additional malignancies which were mammographically and sonographically occult n the ipsilateral and contralateral breast. MR imaging was useful in assessing disease extent and multifocality before surgery.
Lymphatic vessel invasion and lymph node spread is frequent in IMPC and its incidence is reported to be 72-95% (17, 18) . In our study, metastatic axillary lymph nodes were histologically confirmed in 25 breasts (78%). This prevalence is comparable to previous studies, which described metastatic lymph nodes in 80% of patients. This high positive rate of metastatic lymph nodes means that sentinel lymph node biopsy may not beneficial for these patients (12) . Axillary lymph node metastasis was predicted well on ultrasound (64%), but even with equivocal cortical thickening less than 3 mm, lymph node metastasis was proved by US-guided fine needle aspiration. Due to high prevalence of lymphatic metastasis, normallooking lymph nodes on US were frequently proved to have metastases.
Extensive intraductal component was observed in nine tumors (37%). Most of the tumors showed high nuclear grade (58%) and poorly differentiated histologic grade (50%). These are independent of aggressive behavior of IMPC (17) .
IMPC is characterized by higher rates of ER and PR expression (18-21) Zekioglu et al. (18) reported the percentages of ER and PR positivity to be 68% and 61% and the prevalence of c-erbB-2 and p53 proteins to be 54% and 48%, respectively, for IMPCs. Walsh and Bleiweiss (20) reported high percentages of ER and PR positivity (90% and 70%, respectively) and nearly double the expected percentage of c-erbB-2 positivity (60%). These results are higher than those of common breast cancers including IDCs. Yun et al. (21) reported high percentages of ER and lower percentage of PR positivity (93% and 52%, respectively). In our study, the expressions of ER (81%) and PR (71%) were higher than the results of the previous studies. The prevalence of c-erbB-2 (43%) was lower than the result of previous studies for IMPCs, but higher than the prevalence of common breast cancers.
The percentage of hormone receptor positivity for IMPC is higher than for invasive ductal carcinoma, but ER and PR positivity or expression of c-erbB-2 or p53 are not reliable criteria for the discrimination of IMPC from conventional invasive ductal carcinoma (18) . High expression of c-erbB-2 and p53, high proliferation index, low expression of steroid hormone receptors are related to the unfavorable prognostic factors (17) .
Our study had some limitations. First, this is a singleinstitution data set and the patients were retrospectively analyzed and thus the possibility of selection bias should be considered. The category and image findings of tumors could be overestimated because of the reviewers knew the pathologic result of the tumors. However, we attempted to recruit consecutive patients in order to avoid any selection bias. Second, the study lacks a control group composed of patients who were diagnosed with IDC, not otherwise specified (IDC, NOS). Third, we could not analyze new imaging modality, such as elastography on sonography and diffusion weighted image (DWI) or spectroscopy on MR imging, which can aid in differentiation of subtype of breast cancer. Further study using elastography, DWI and spectroscopy in patients with IPMC would be necessary to better understand the difference between IDC and IPMC.
In conclusion, dynamic MR imaging may be used for better delineation of disease extent in IMPC of the breast than can be obtained with sonography or mammography, and it has a role in surgical planning. IMPC manifested as typical malignant morphologic features with washout pattern on MR imaging, and multiplicity and combined pattern were common.
Axillary lymph node metastasis is commonly associated and this is the hallmark of IMPC. Awareness of these MR imaging findings should be helpful to predict IMPC and to decide aggressive surgical plan including axillary surgery.
